| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/18/2008 | WO2008110070A1 Double-unit tablet comprising acid labile drug |
| 09/18/2008 | WO2008110035A1 A pharmaceutical composition containing inclusion compound of cyclodextrin and adefovir dipivoxil and preparative method thereof |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2008089339A3 Oligosaccharide conjugates for cellular targeting |
| 09/18/2008 | WO2008070721A3 High protein concentration formulations containing mannitol |
| 09/18/2008 | WO2008065451A3 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 09/18/2008 | WO2008062453A3 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form |
| 09/18/2008 | WO2008005318A3 Chewy products and methods for making the same |
| 09/18/2008 | WO2007147052A3 Topical compositions |
| 09/18/2008 | US20080228268 Method of Formation of Viscous, Shape Conforming Gels and Their Uses as Medical Prosthesis |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227872 A polyoxyethylene glycol with an end group 1-benzotriazolylcarbonate ester; reacted with lysine to form a water-soluble and non-peptidic to form a biologically active polymer conjugate; one step preparation; phosgene-free; drug delivery; bioavailability; protease resistant; nonimmunogenic; quality |
| 09/18/2008 | US20080227871 Ampholytic Copolymer, Production Thereof, and Use of the Same |
| 09/18/2008 | US20080227861 Inhibition of Allergic Contact Dermatitis By N-L-ALPHA-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 09/18/2008 | US20080227763 Administering hormone replacement therapy by applying a gel of Nomegestrol or Nomegestrol acetate to the skin; restoring genital bleeding in menopausal women |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227715 Liquid composition of factor VII polypeptides |
| 09/18/2008 | US20080227690 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080226995 Having thermodynamically reversible Diels Alder bond; noncoated; tissue engineering, permeable membranes, packaging materials |
| 09/18/2008 | US20080226741 Biodegradable; drug delivery |
| 09/18/2008 | US20080226739 Hierarchically self-assembling linear-dendritic hybrid polymers for delivery of biologically active agents |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226730 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080226725 New and Advantageous Hydrogel Composition |
| 09/18/2008 | US20080226722 Gel Composition Comprising Charged Polymers |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226712 Mixture with tablet distegrant; sustained release; embedding water soluble particle in plastic membrane coating ; stomach disorders |
| 09/18/2008 | US20080226705 Gel delivery system for oral administration of medicaments |
| 09/18/2008 | US20080226704 Method of Producing Coated Fine Particles |
| 09/18/2008 | US20080226699 Method and System for Rapid Transdermal Administration |
| 09/18/2008 | US20080226697 Mixture of transdermal absorption promoter and drug; stabilized with polyvinylpyrrolidone; prevent vaporization or degradation |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226689 Apparatus for uniform delivery of drugs to biological systems |
| 09/18/2008 | US20080226682 Mixture comprising lectin, isoflavone and saponin for use in enhancing oral administration of pharmaceuticals |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226672 Adjuvant Systems and Vaccines |
| 09/18/2008 | US20080226659 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/18/2008 | US20080226657 Monomethylvaline compounds capable of conjugation to ligands |
| 09/18/2008 | US20080226656 RG1 antibodies and uses thereof |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders |
| 09/18/2008 | US20080226625 Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 09/18/2008 | US20080226623 Stabilized protein crystals, formulations comprising them and methods of making them |
| 09/18/2008 | US20080226616 Mixture comprising polyacrylic acid salts, acrylate/C10-30 alkyl acrylate crosspolymer and carrageenan for use as agent which reduces cellulite and skin irregularities |
| 09/18/2008 | US20080226605 Methods and Compositions Facilitating Entry of Compounds Into Cells |
| 09/18/2008 | US20080226583 Therapeutic polyesters and polyamides |
| 09/18/2008 | US20080226579 Using water soluble ion exchange resin; stability; masking bitter taste |
| 09/18/2008 | US20080226564 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/18/2008 | CA2680535A1 Binding ligand linked drug delivery conjugates of tubulysins |
| 09/18/2008 | CA2680193A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679482A1 Oligomer-protease inhibitor conjugates |
| 09/18/2008 | CA2679479A1 Oligomer-opioid agonist conjugates |
| 09/18/2008 | CA2679473A1 De novo synthesis of conjugates |
| 09/18/2008 | CA2679070A1 Oligomer-antihistamine conjugates |
| 09/18/2008 | CA2679050A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | CA2678876A1 Orally administrable films |
| 09/18/2008 | CA2676981A1 Powders for reconstitution |
| 09/17/2008 | EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies |
| 09/17/2008 | EP1970366A1 Isohumulone compound clathrate and composition containing the same |
| 09/17/2008 | EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 09/17/2008 | EP1970077A1 A biogradable material with nanopores and electric conductivity and the fabricating method thereof |
| 09/17/2008 | EP1970076A1 Pharmaceutical composition for application to nail |
| 09/17/2008 | EP1970054A2 Clopidogrel tablets |
| 09/17/2008 | EP1970052A2 Basic drug compositions with enhanced bioavailability |
| 09/17/2008 | EP1970040A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 09/17/2008 | EP1968711A2 Dermatological viscoelastic gel |
| 09/17/2008 | EP1968649A1 Protein nanoparticles and the use of the same |
| 09/17/2008 | EP1968644A2 Polymer conjugates of glp-1 |
| 09/17/2008 | EP1968643A2 Cell penetrating peptide conjugates for delivering of nucleic acids into a cell |
| 09/17/2008 | EP1968642A2 Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups |
| 09/17/2008 | EP1968641A2 Production of conjugates |
| 09/17/2008 | EP1968640A1 Compounds for use in treating abnormal cell proliferation, and methods of producing same |
| 09/17/2008 | EP1968639A1 Compositions formulated for solvent-regulated drug release |
| 09/17/2008 | EP1968638A1 Controlled release gels |
| 09/17/2008 | EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 09/17/2008 | EP1968595A2 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 09/17/2008 | EP1968592A2 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 09/17/2008 | EP1968556A1 Composition, and use thereof, in respect if cancer, prophylactic treatment and infection in the urinary tract, involving nitric oxide |
| 09/17/2008 | EP1968550A2 Nanoclusters for delivery of therapeutics |
| 09/17/2008 | EP1968537A1 Pharmaceutical compositions stabilized in glassy particles |
| 09/17/2008 | EP1890687B1 Stable pharmaceutical gel of diclofenac sodium |
| 09/17/2008 | EP1796668B1 Aqueous pharmaceutical preparation comprising roflumilast |
| 09/17/2008 | EP1753293A4 Anti-microbial activity of biologically stabilized silver nano particles |
| 09/17/2008 | EP1677687A4 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
| 09/17/2008 | EP1588162B1 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 09/17/2008 | EP1503733B1 Oleaginous oral antiparasitic compositions |
| 09/17/2008 | EP1432409B1 Granulate or powder for producing coating or binding agents for medicaments |
| 09/17/2008 | EP1404373B1 Pna conjugate for the treatment of diseases associated with hiv |
| 09/17/2008 | EP1297838B1 Pralmorelin-containing nasal drop preparations |
| 09/17/2008 | EP1296554B1 Prevention and treatment of mycoplasma-associated diseases using trans-sialidase and/or neuraminidase |
| 09/17/2008 | EP1202748B1 Polycation-based bioconjugates |
| 09/17/2008 | EP1159441B1 Delivery of nucleic acids and proteins to cells |
| 09/17/2008 | CN101268118A Method for preparing polymer maleimides |